Oral Estradiol Appetite & Cravings Changes: What the Evidence Shows

At a glance

  • Approved uses / Hot flashes, vulvar and vaginal atrophy, low estrogen from hypogonadism or ovarian failure, palliative breast and prostate cancer, osteoporosis prevention [1]
  • Appetite and cravings / Not named among reactions reported with estrogen therapy on the oral tablet label [1]
  • Weight on the label / 'Increase or decrease in weight' and 'reduced carbohydrate tolerance,' listed without frequencies [1]
  • Large trials / WHI reported heart, stroke, cancer, clot and fracture outcomes, not appetite [2][3]
  • Usual oral starting dose / The label gives an initial range of 1 to 2 mg daily, adjusted to symptoms [1]

Does oral estradiol change appetite or cravings?

The oral estradiol tablet label is the most specific information on this question. It lists, without frequencies, reactions reported with estrogen therapy. Among them are 'increase or decrease in weight' and 'reduced carbohydrate tolerance,' along with nausea, vomiting, abdominal cramps and bloating [1]. Appetite and food cravings are not named in that list [1].

What the label lists about weight and eating

The same label section also lists gallbladder disease, increased blood pressure, edema, headache, mood changes and changes in vaginal bleeding [1].

Weight is listed in both directions, and the label gives no frequency for either [1]. A change on the scale during oral estradiol therapy is therefore a listed possibility, not proof that appetite changed.

What the large hormone therapy trials measured

The Women's Health Initiative enrolled 16,608 postmenopausal women with a uterus in its estrogen-plus-progestin trial, which used conjugated equine estrogens 0.625 mg plus medroxyprogesterone acetate 2.5 mg [2]. Its estrogen-alone trial enrolled 10,739 women with a prior hysterectomy and used conjugated equine estrogens 0.625 mg [3]. Both trials were stopped early [2][3].

The outcomes reported were coronary heart disease, invasive breast cancer, stroke, pulmonary embolism, colorectal cancer, hip fracture and death [2][3]. Neither trial tested estradiol, so their results do not answer whether oral estradiol changes appetite or weight. The Climara label notes that only daily oral conjugated estrogens 0.625 mg were studied in the estrogen-alone substudy. It says the relevance of those findings to lower doses, other routes of administration or other estrogen-alone products is not known [4].

Frequently asked questions

Does oral estradiol suppress appetite?
The oral estradiol label does not list appetite as a reaction. It lists 'increase or decrease in weight' and 'reduced carbohydrate tolerance' among reactions reported with estrogen therapy, without giving frequencies [1].
Will oral estradiol make me gain weight?
The label lists 'increase or decrease in weight' among reactions reported with estrogen therapy, without a frequency, so it does not settle the question in either direction [1].
Is oral estradiol approved for weight loss or appetite control?
No. The labeled indications are moderate to severe menopausal vasomotor symptoms, moderate to severe vulvar and vaginal atrophy, low estrogen from hypogonadism, castration or primary ovarian failure, palliative breast and prostate cancer, and prevention of postmenopausal osteoporosis [1].
Does the label mention food cravings?
It does not name cravings. It lists 'reduced carbohydrate tolerance' among reactions reported with estrogen therapy, without a frequency [1].

References

  1. U.S. National Library of Medicine, DailyMed. Estradiol tablets USP (Teva) prescribing information. Estradiol tablets USP (Teva) label
  2. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-33. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial
  3. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701-12. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial
  4. U.S. National Library of Medicine, DailyMed. Climara estradiol transdermal system (Bayer) prescribing information. Climara estradiol transdermal system (Bayer) label
Evidence overview for Oral Estradiol Appetite & Cravings Changes: What the Evidence Shows